Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus)

Erik Rytting, Xiao-Ming Wang, Daria I. Vernikovskaya, Ying Zhan, Cassondra Bauer, Susan M. Abdel-Rahman, Mahmoud Ahmed, Tatiana Nanovskaya

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Recent in vitro data obtained in our laboratory revealed similarities between baboons and humans in the biotransformation of bupropion (BUP) by both hepatic and placental microsomes. These data supported the use of baboons to study BUP biotransformation during pregnancy. The aim of this investigation was to determine the pharmacokinetics of BUP in baboons during pregnancy and postpartum, as well as fetal exposure to the drug after intravenous administration. Pregnant baboons (n = 5) received a single intravenous bolus dose of bupropion hydrochloride (1 mg/kg) at gestational ages 94-108 days (midpregnancy), 142-156 days (late pregnancy), and 6 weeks postpartum. Blood and urine samples were collected for 12 and 24 hours, respectively. The concentrations of BUP, hydroxybupropion (OH-BUP), threohydrobupropion, and erythrohydrobupropion in plasma were determined by liquid chromatography-tandem mass spectrometry. Relative to the postpartum period, the average midpregnancy clearance of BUP trended higher (3.6 ± 0.15 versus 2.7 ± 0.28 l/h per kg) and the average Cmax (294 v 91 versus 361 ± 64 ng/ml) and the area under the curve (AUC) of BUP values (288 ± 22 versus 382 ± 42 h·ng/ml) trended lower. AUCOH-BUP also tended to be lower midpregnancy compared with postpartum (194 ± 76 versus 353 ± 165 h·ng/ml). Whereas the observed trend toward increased clearance of BUP during baboon pregnancy could be associated with a pregnancy-induced increase in its biotransformation, the trend toward increased renal elimination of OH-BUP may overshadow any corresponding change in the hydroxylation activity of CYP2B. Copyright

Original languageEnglish (US)
Pages (from-to)1773-1779
Number of pages7
JournalDrug Metabolism and Disposition
Volume42
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Papio cynocephalus
Bupropion
Papio
Postpartum Period
Pregnancy
Biotransformation
Hydroxylation
Microsomes
Tandem Mass Spectrometry
Liquid Chromatography
Intravenous Administration
Gestational Age
Area Under Curve
Pharmacokinetics
Urine

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus). / Rytting, Erik; Wang, Xiao-Ming; Vernikovskaya, Daria I.; Zhan, Ying; Bauer, Cassondra; Abdel-Rahman, Susan M.; Ahmed, Mahmoud; Nanovskaya, Tatiana.

In: Drug Metabolism and Disposition, Vol. 42, No. 10, 01.10.2014, p. 1773-1779.

Research output: Contribution to journalArticle

Rytting, Erik ; Wang, Xiao-Ming ; Vernikovskaya, Daria I. ; Zhan, Ying ; Bauer, Cassondra ; Abdel-Rahman, Susan M. ; Ahmed, Mahmoud ; Nanovskaya, Tatiana. / Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus). In: Drug Metabolism and Disposition. 2014 ; Vol. 42, No. 10. pp. 1773-1779.
@article{eb3311e314f6463487fafcfacf36e3ec,
title = "Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus)",
abstract = "Recent in vitro data obtained in our laboratory revealed similarities between baboons and humans in the biotransformation of bupropion (BUP) by both hepatic and placental microsomes. These data supported the use of baboons to study BUP biotransformation during pregnancy. The aim of this investigation was to determine the pharmacokinetics of BUP in baboons during pregnancy and postpartum, as well as fetal exposure to the drug after intravenous administration. Pregnant baboons (n = 5) received a single intravenous bolus dose of bupropion hydrochloride (1 mg/kg) at gestational ages 94-108 days (midpregnancy), 142-156 days (late pregnancy), and 6 weeks postpartum. Blood and urine samples were collected for 12 and 24 hours, respectively. The concentrations of BUP, hydroxybupropion (OH-BUP), threohydrobupropion, and erythrohydrobupropion in plasma were determined by liquid chromatography-tandem mass spectrometry. Relative to the postpartum period, the average midpregnancy clearance of BUP trended higher (3.6 ± 0.15 versus 2.7 ± 0.28 l/h per kg) and the average Cmax (294 v 91 versus 361 ± 64 ng/ml) and the area under the curve (AUC) of BUP values (288 ± 22 versus 382 ± 42 h·ng/ml) trended lower. AUCOH-BUP also tended to be lower midpregnancy compared with postpartum (194 ± 76 versus 353 ± 165 h·ng/ml). Whereas the observed trend toward increased clearance of BUP during baboon pregnancy could be associated with a pregnancy-induced increase in its biotransformation, the trend toward increased renal elimination of OH-BUP may overshadow any corresponding change in the hydroxylation activity of CYP2B. Copyright",
author = "Erik Rytting and Xiao-Ming Wang and Vernikovskaya, {Daria I.} and Ying Zhan and Cassondra Bauer and Abdel-Rahman, {Susan M.} and Mahmoud Ahmed and Tatiana Nanovskaya",
year = "2014",
month = "10",
day = "1",
doi = "10.1124/dmd.114.058255",
language = "English (US)",
volume = "42",
pages = "1773--1779",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "10",

}

TY - JOUR

T1 - Metabolism and disposition of bupropion in pregnant baboons (Papio cynocephalus)

AU - Rytting, Erik

AU - Wang, Xiao-Ming

AU - Vernikovskaya, Daria I.

AU - Zhan, Ying

AU - Bauer, Cassondra

AU - Abdel-Rahman, Susan M.

AU - Ahmed, Mahmoud

AU - Nanovskaya, Tatiana

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Recent in vitro data obtained in our laboratory revealed similarities between baboons and humans in the biotransformation of bupropion (BUP) by both hepatic and placental microsomes. These data supported the use of baboons to study BUP biotransformation during pregnancy. The aim of this investigation was to determine the pharmacokinetics of BUP in baboons during pregnancy and postpartum, as well as fetal exposure to the drug after intravenous administration. Pregnant baboons (n = 5) received a single intravenous bolus dose of bupropion hydrochloride (1 mg/kg) at gestational ages 94-108 days (midpregnancy), 142-156 days (late pregnancy), and 6 weeks postpartum. Blood and urine samples were collected for 12 and 24 hours, respectively. The concentrations of BUP, hydroxybupropion (OH-BUP), threohydrobupropion, and erythrohydrobupropion in plasma were determined by liquid chromatography-tandem mass spectrometry. Relative to the postpartum period, the average midpregnancy clearance of BUP trended higher (3.6 ± 0.15 versus 2.7 ± 0.28 l/h per kg) and the average Cmax (294 v 91 versus 361 ± 64 ng/ml) and the area under the curve (AUC) of BUP values (288 ± 22 versus 382 ± 42 h·ng/ml) trended lower. AUCOH-BUP also tended to be lower midpregnancy compared with postpartum (194 ± 76 versus 353 ± 165 h·ng/ml). Whereas the observed trend toward increased clearance of BUP during baboon pregnancy could be associated with a pregnancy-induced increase in its biotransformation, the trend toward increased renal elimination of OH-BUP may overshadow any corresponding change in the hydroxylation activity of CYP2B. Copyright

AB - Recent in vitro data obtained in our laboratory revealed similarities between baboons and humans in the biotransformation of bupropion (BUP) by both hepatic and placental microsomes. These data supported the use of baboons to study BUP biotransformation during pregnancy. The aim of this investigation was to determine the pharmacokinetics of BUP in baboons during pregnancy and postpartum, as well as fetal exposure to the drug after intravenous administration. Pregnant baboons (n = 5) received a single intravenous bolus dose of bupropion hydrochloride (1 mg/kg) at gestational ages 94-108 days (midpregnancy), 142-156 days (late pregnancy), and 6 weeks postpartum. Blood and urine samples were collected for 12 and 24 hours, respectively. The concentrations of BUP, hydroxybupropion (OH-BUP), threohydrobupropion, and erythrohydrobupropion in plasma were determined by liquid chromatography-tandem mass spectrometry. Relative to the postpartum period, the average midpregnancy clearance of BUP trended higher (3.6 ± 0.15 versus 2.7 ± 0.28 l/h per kg) and the average Cmax (294 v 91 versus 361 ± 64 ng/ml) and the area under the curve (AUC) of BUP values (288 ± 22 versus 382 ± 42 h·ng/ml) trended lower. AUCOH-BUP also tended to be lower midpregnancy compared with postpartum (194 ± 76 versus 353 ± 165 h·ng/ml). Whereas the observed trend toward increased clearance of BUP during baboon pregnancy could be associated with a pregnancy-induced increase in its biotransformation, the trend toward increased renal elimination of OH-BUP may overshadow any corresponding change in the hydroxylation activity of CYP2B. Copyright

UR - http://www.scopus.com/inward/record.url?scp=84907918836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907918836&partnerID=8YFLogxK

U2 - 10.1124/dmd.114.058255

DO - 10.1124/dmd.114.058255

M3 - Article

C2 - 25097227

AN - SCOPUS:84907918836

VL - 42

SP - 1773

EP - 1779

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 10

ER -